Literature DB >> 1684241

No evidence for endorphin deficiency in fibromyalgia following investigation of cerebrospinal fluid (CSF) dynorphin A and Met-enkephalin-Arg6-Phe7.

Henning Vaerøy1, Fred Nyberg, Lars Terenius.   

Abstract

The CSF levels of Met-enkephalin-Arg6-Phe7 and dynorphin A were measured in patients with fibromyalgia. The mean CSF Met-enkephalin-Arg6-Phe7 level was 35.1 +/- 2.4 fmol/ml (mean +/- S.E.M.). The mean CSF level of dynorphin A was 14.3 +/- 0.9 fmol/ml. Regression analysis showed a statistically significant correlation between Met-enkephalin-Arg6-Phe7 and dynorphin A (r = 0.5369, P = 0.001). When correlated to the previously measured CSF levels of beta-endorphin, a statistically significant correlation was found with Met-enkephalin-Arg6-Phe7 (r = 0.5055, P = 0.03) but not with dynorphin A (P greater than 0.05). The Met-enkephalin-Arg6-Phe7 and dynorphin A levels are elevated compared to the levels available for comparison groups. Therefore, a lack of endorphin secretion does not seem to be the basis for the hyperalgesia observed in these patients.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1684241     DOI: 10.1016/0304-3959(91)90068-9

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  15 in total

Review 1.  Review of overlap between thermoregulation and pain modulation in fibromyalgia.

Authors:  Alice A Larson; José V Pardo; Jeffrey D Pasley
Journal:  Clin J Pain       Date:  2014-06       Impact factor: 3.442

Review 2.  Pain complaints in patients with fibromyalgia versus chronic fatigue syndrome.

Authors:  L A Bradley; N L McKendree-Smith; G S Alarcón
Journal:  Curr Rev Pain       Date:  2000

3.  Nociceptive aspects of fibromyalgia.

Authors:  A A Larson; K J Kovács
Journal:  Curr Pain Headache Rep       Date:  2001-08

Review 4.  Musculoskeletal injury as a trigger for fibromyalgia/posttraumatic fibromyalgia.

Authors:  D Buskila; L Neumann
Journal:  Curr Rheumatol Rep       Date:  2000-04       Impact factor: 4.592

Review 5.  The Emerging Role of Spinal Dynorphin in Chronic Pain: A Therapeutic Perspective.

Authors:  Sonia Podvin; Tony Yaksh; Vivian Hook
Journal:  Annu Rev Pharmacol Toxicol       Date:  2016       Impact factor: 13.820

Review 6.  Fibromyalgia: A Critical and Comprehensive Review.

Authors:  Andrea T Borchers; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2015-10       Impact factor: 8.667

Review 7.  Psychosocial aspects of fibromyalgia.

Authors:  W R Nielson; H Merskey
Journal:  Curr Pain Headache Rep       Date:  2001-08

Review 8.  Is fibromyalgia a neurologic disease?

Authors:  Laurence A Bradley; Nancy L McKendree-Smith; Graciela S Alarcón; Leanne R Cianfrini
Journal:  Curr Pain Headache Rep       Date:  2002-04

9.  Estradiol treatment prevents injury induced enhancement in spinal cord dynorphin expression.

Authors:  Daya S Gupta; Charles H Hubscher
Journal:  Front Physiol       Date:  2012-02-22       Impact factor: 4.566

10.  Effects of naltrexone on pain sensitivity and mood in fibromyalgia: no evidence for endogenous opioid pathophysiology.

Authors:  Jarred W Younger; Alex J Zautra; Eric T Cummins
Journal:  PLoS One       Date:  2009-04-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.